A team from the Margarita Salas Biological Research Center (CIB Margarita Salas-CSIC) has verified the efficacy of drugs, already used clinically, in virus infections such as SARS-CoV2, among others. The results demonstrate how these drugs, called MTAs, inhibit viral infection. They target microtubules, structures inside cells used by viruses for replication. The team used the ALBA Synchrotron to see how these drugs bind to the protein that forms the microtubules, obtaining a three-dimensional image of this drug-protein union. By adhering to it, the drug blocks the protein, preventing the formation of the microtubule and, therefore, the replication of the virus.
The 10th ALBA beamline is fully operational and hosted last week its first experiment from experts users. Researchers from the ICMAB-CSIC, involved in the CSIC PTI-Transener+, were studying different types of materials for batteries. NOTOS is co-funded by the European Regional Development Fund (ERDF).
A team from Max Planck Institute has developed control of oxygen defects and magnetic properties in SrCoOx thin films via ionic liquid gating. XAS & XMCD spectroscopy at BOREAS beamline of the ALBA Synchrotron was used to characterise the resulting properties.
Altinco company uses the ALBA Synchrotron to improve the efficacy of its new product, which optimizes the pruning of different crop varieties. The results obtained at ALBA have enabled Altinco to characterize its product and thus facilitate its registration under the European Chemicals Agency.
Researchers from Spain and the United States, in collaboration with ALBA, have developed a new structural model for polymer materials: the semi-paracrystallinity. The experiments performed at NCD-SWEET beamline were key to reveal the semi-paracrystalline organization of the polymers, which is of paramount importance for the further development of these materials in organic electronic technologies.
